The EMA accepts to assess the MAA from PharmaMar for AplidinĀ®
PharmaMar (MSE:PHM) has announced today that the European Medicines Agency (EMA) has accepted to assess the Marketing Authorization Application (MAA) for AplidinĀ® (plitidepsin) in combination...